What a Pharmacist Needs to Know about Bariatric Surgery: Compounding Opportunities
Download in electronic PDF format for $75
Abstract: Approximately two thirds of adults in the United States are overweight or obese. The National Institutes of Health report that obesity is associated with higher rates of morbidity and mortality. Healthcare spending for obese persons is 37% higher than spending for individuals of healthy weight. Losing weight decreases the risk of diabetes, hyperlipidemia, and cardiovascular disease, as well as other chronic diseases. Weight-loss surgery, also known as bariatric surgery, is usually limited to the morbidly obese, those with a body mass index (BMI) = 40, or = 35 with some comorbid conditions. Bariatric surgery involves reducing the size of the gastric reservoir to decrease the amount of calories the patient is able to ingest. The surgery is considered not a cosmetic procedure but the only proven method to achieve long-term weight control for the severely obese, when accompanied by lifestyle and behavior modifications. Of primary concern to pharmacists for patients who have undergone bariatric surgery are drugs that may potentially harm the stomach pouch that remains after surgery, nutritional deficiencies, and dumping syndrome. Decreased acid in the stomach pouch affects the patient’s ability to process drugs and nutrition. One of the most common problems following bariatric surgery is calcium deficiency. Patients who have undergone bariatric surgery present numerous compounding opportunities in the areas of nutrition, pain management, electrolyte balance, hair loss, and skin problems, among others.
Related Keywords:
obesity, weight loss, malabsorption, nutritional deficiency, body mass index, BMI, dumping syndrome
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
What a Pharmacist Needs to Know about Bariatric Surgery: Compounding Opportunities
Collier Kathleen, Beard Janet
|
Mar/Apr 2005
Pg. 111-115
|
Basics of Compounding: Providing Pharmacy Services to Bariatric Surgery Patients
McElhiney Linda F
|
Jan/Feb 2018
Pg. 30-39
|
Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R, Newton Gail D
|
May/Jun 2004
Pg. 181-185
|
Basics of Compounding: Certification of Sterile Equipment and Facilities: What Pharmacists Need to Know
Lanze Amanda, Rudner Shara
|
Sep/Oct 2014
Pg. 397-399
|
Calculations
Stockton Shelly J
|
Sep/Oct 2014
Pg. 407
|
Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
|
Jul/Aug 2004
Pg. 269-274
|
Providing Consultation Services for Wellness Issues Related to Exercise, Weight Management, and Nutritional Support: Key Lifestyle Modification for Healthier Aging
Biundo Bruce
|
Jan/Feb 2010
Pg. 26-31
|
Calculations
Stockton Shelly J
|
Mar/Apr 2016
Pg. 142
|
Calculations
Stockton Shelly J
|
Sep/Oct 2017
Pg. 406
|
Calculations
Stockton Shelly J
|
Jul/Aug 2013
Pg. 324
|
Compounded Tirzepatide Therapy for Weight Loss: A Health Economics & Outcomes Research (HEOR) Analysis
Guth Michael AS
|
Jan/Feb 2025
Pg. 52-63
|
Three Things You Need to Know Right Now
Brunner Scott
|
May/Jun 2022
Pg. 211-213
|
Calculations: Evaluation of Body Weight and Units of Activity
Stockton Shelly J
|
Sep/Oct 2024
Pg. 394-395
|
Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome)
Riepl Mike
|
May/Jun 2019
Pg. 192-199
|
Equine Cushing’s Syndrome
Vail Jane
|
Jan/Feb 2003
Pg. 27-29
|
Calculations
Stockton Shelly J
|
Jan/Feb 2007
Pg. 68
|
Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States
Lobb William B, Wilkin Noel E, Holmes Erin R
|
Nov/Dec 2015
Pg. 514-520
|
Estradiol: The Emerging Evidence for a Protective Role Against Insulin Resistance and Obesity
Biundo Bruce, Gogola Margaret
|
Jul/Aug 2015
Pg. 289-293
|
Calculations
Stockton Shelly J
|
May/Jun 2019
Pg. 229
|
The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists
Parks Kenneth Chase, Bernard Brian, Cogdill Christopher Blake
|
Sep/Oct 2015
Pg. 377-380
|
Return to Top |